Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 3,440,345 9.960% | 243,899 (+7.63%) | Filing History |
| 2024-02-13 5:19 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,684,005 7.800% | 887,626 (+49.41%) | Filing History |
| 2024-02-13 5:07 pm Purchase | 2023-12-29 | 13G | KalVista Pharmaceuticals, Inc. KALV | The Vanguard Group | 1,781,419 5.150% | 1,781,419 (New Position) | Filing History |
| 2024-02-12 8:30 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Saturn V Capital Management LP | 1,431,259 4.100% | 1,431,259 (New Position) | Filing History |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 50,970 0.147% | -1,260,032 (-96.11%) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | BlackRock Inc. BLK | 2,242,025 6.500% | 669,604 (+42.58%) | Filing History |
| 2023-12-28 4:16 pm Purchase | 2023-12-26 | 13G | KalVista Pharmaceuticals, Inc. KALV | Venrock Healthcare Capital Partners III, L.P. | 3,573,714 10.300% | 657,047 (+22.53%) | Filing History |
| 2023-12-14 1:33 pm Purchase | 2023-12-12 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,582,294 10.400% | 343,435 (+10.60%) | Filing History |
| 2023-03-10 5:15 pm Purchase | 2023-01-25 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,379 5.300% | 724,077 (+67.53%) | Filing History |
| 2023-02-14 4:59 pm Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Great Point Partners, LLC | 1,055,801 3.100% | -224,199 (-17.52%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 3,196,446 9.400% | 1,796,446 (+128.32%) | Filing History |
| 2023-02-14 08:41 am Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital, LP | 0 0.000% | -1,500,000 (Position Closed) | Filing History |
| 2023-02-13 5:44 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Capital IX, LLC | 772,068 2.300% | 772,068 (New Position) | Filing History |
| 2023-02-13 10:51 am Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,072,302 3.100% | -673,998 (-38.60%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,311,002 5.325% | 299,502 (+29.61%) | Filing History |
| 2023-02-06 3:02 pm Sale | 2022-12-30 | 13G | KalVista Pharmaceuticals, Inc. KALV | Wellington Management Group LLP | 0 0.000% | -1,811,505 (Position Closed) | Filing History |
| 2023-01-31 2:18 pm Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | FRANKLIN RESOURCES INC BEN | 0 0.000% | -1,252,142 (Position Closed) | Filing History |
| 2023-01-09 4:19 pm Purchase | 2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV | TCG Crossover GP I, LLC | 3,408,081 9.900% | 3,408,081 (New Position) | Filing History |
| 2023-01-09 4:06 pm Purchase | 2022-12-28 | 13G | KalVista Pharmaceuticals, Inc. KALV | Venrock Healthcare Capital Partners III, L.P. | 2,916,667 8.600% | 2,916,667 (New Position) | Filing History |
| 2023-01-06 1:46 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | BlackRock Inc. BLK | 1,572,421 4.600% | 67,801 (+4.51%) | Filing History |